17336
4-(2-Fmoc-hydrazino)benzoic acid
≥95.0% (HPLC)
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C22H18N2O4
CAS Number:
Molecular Weight:
374.39
UNSPSC Code:
12352200
NACRES:
NA.26
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
8082614
InChI
1S/C22H18N2O4/c25-21(26)14-9-11-15(12-10-14)23-24-22(27)28-13-20-18-7-3-1-5-16(18)17-6-2-4-8-19(17)20/h1-12,20,23H,13H2,(H,24,27)(H,25,26)
SMILES string
OC(=O)c1ccc(NNC(=O)OCC2c3ccccc3-c4ccccc24)cc1
InChI key
MLVJMSRGLQCZDE-UHFFFAOYSA-N
assay
≥95.0% (HPLC)
reaction suitability
reaction type: solution phase peptide synthesis, reagent type: linker
impurities
≤1% water, ≤5% residual solvent
application(s)
peptide synthesis
functional group
Fmoc
storage temp.
2-8°C
Storage Class
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Michele Filippo Buono et al.
Cells, 9(7) (2020-07-24)
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardium. The development of a novel in vitro model could help to better emulate healthy and diseased human heart conditions and may improve the understanding of disease
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service